ESR1 and breast carcinoma: Spadazzi et al. have identified trefoil factor 1 (TFF1) as strictly correlated to bone metastasis from estrogen receptor (ER) + breast cancer, and TFF1 upregulation could be useful to identify patients at high risk of bone metastasis [12].